Inflammatory myofibroblastic tumour (IMT) is a fibroblastic and myofibroblastic neoplasm of intermediate biological potential because of its tendency for local recurrence and rare incidence of metastasis [1]. This distinctive neoplasm… Click to show full abstract
Inflammatory myofibroblastic tumour (IMT) is a fibroblastic and myofibroblastic neoplasm of intermediate biological potential because of its tendency for local recurrence and rare incidence of metastasis [1]. This distinctive neoplasm is composed of myofibroblastic cells accompanied by an inflammatory infiltrate of plasma cells, lymphocytes, and eosinophils. It is extremely rare in the liver and was first described by Pack and Baker in 1953 [2]. The true incidence has still not been reported in the literature. However, the postulated incidence is as low as 0.7% [3]. IMTof the liver is challenging to diagnose not only due to low incidence but also because of non-specific clinical, laboratory, or radiological features. Diagnosis mainly relies on the histopathological examination. Herein, we report a case of 23-year old male who presented with synchronous IMT of the liver and pancreatic carcinoma. Such a synchronous presentation has not been described in the literature till date. IMT of the liver was clinically and radiologically misdiagnosed in our case as abscess or metastasis. This had implications on the staging and treatment of the patient as the presence of large hepatic metastasis in pancreatic carcinoma, which itself is one of the most aggressive tumour with a 5-year survival rate below 5%, would have rendered the patient unfit for surgery [3]. A timely diagnosis with the frozen section in our patient helped in the accurate management of the patient.
               
Click one of the above tabs to view related content.